Genentech

$1.4M revenue • 8 employees • United States

Last Updated May 1, 2025

Company Overview

Company Name

Genentech

Address

United States

Website

carmot.us

Approx. Annual Revenue

$1.4M

Employees

8

Established

2008

About Genentech

Genentech: Carmot Therapeutics is a biopharmaceutical company based in the United States. The company is focused on developing innovative treatments for obesity, type 1 diabetes, and type 2 diabetes, with three clinical-stage assets in its pipeline. Carmot Therapeutics is currently conducting clinical trials to evaluate the safety, tolerability, and efficacy of its GLP-1/GIP receptor agonists and GLP-1 receptor agonist.

Business Profile

Read from the Genentech website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
9/10 · Current and complete site; Clear navigation and content
Footer copyright year
2026

Recent changes

What changed on the Genentech website and Google listing, as detected by Coldlytics on each visit.

  1. TikTok pixel installed

  2. LinkedIn Insight tag installed

  3. Google Ads pixel installed

  4. Meta (Facebook) ad pixel installed

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →

Biotech & Life Sciences Companies near CA

Browse all Biotech & Life Sciences companies in California →

Frequently Asked Questions about Genentech

Advertising Pixels

  • Facebook Ad Pixel
  • Google Ad Pixel
  • LinkedIn Ad Pixel
  • TikTok Ad Pixel

Categories

Technologies Used

Social Profiles

Key Decision Makers

Luis Acosta Senior Clinical Trial Manager
LinkedIn
Rohini L. Senior Clinical Trial Manager
LinkedIn
Diana Espinoza Sr. Clinical Trial Manager
LinkedIn
Stacey Toussaint Touson Clinical Trial Manager
LinkedIn